• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Report from SIR: East and West shake hands over liver RFA

Article

Despite distinctive boundaries shaping their work, Asian and European researchers have arrived at the same conclusion: Radiofrequency ablation is as effective as surgical resection for the treatment of single small hepatocellular carcinomas.

Despite distinctive boundaries shaping their work, Asian and European researchers have arrived at the same conclusion: Radiofrequency ablation is as effective as surgical resection for the treatment of single small hepatocellular carcinomas.

"RFA should be considered a first-line therapeutic option for this patient population," said Dr. Riccardo Lencioni, an interventional radiologist from the University of Pisa in Italy.

Lencioni spoke Friday during a press conference at the 2006 Society of Interventional Radiology meeting in Toronto.

Although surgery remains the standard of care for HCC, most patients have a limited hepatic functional reserve because of coexisting cirrhosis. They cannot tolerate surgical resection. RFA offers these patients a nonsurgical option that preserves healthy tissue, is well tolerated, and has a short recovery time, Lencioni said.

Lencioni and colleagues performed a retrospective case-control review of 162 patients from the Tumor Radiofrequency Ablation Italian Network (TRAIN). They evaluated survival, local tumor progression, and recurrence rates for surgery and RFA. Overall three-year survival rates were 65% and 72% for surgery and RFA, respectively. While the local tumor progression rate was significantly higher in the RFA group compared with surgery, the incidence of tumor recurrence was similar between the two groups.

Lencioni's findings matched those published recently by researchers in China who found RFA to be as effective as surgical resection in the treatment of solitary small HCC. The Chinese study entailed the first randomized controlled trial with a large patient population sample comparing both techniques (Ann Surg 2006;243:321-328).

Such a trial has never been possible in the West for various reasons, but the Chinese study was designed to test the same hypothesis as the Italian one, Lencioni said.

"The results are very similar, if not identical. The data from the Chinese study prove RFA can offer a choice that is equivalent to surgery for these patients," he said.

Recent Videos
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Teleradiology and Breast Imaging: Keys to Facilitating Personalized Service, Efficiency and Equity
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 3
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 2
Related Content
© 2025 MJH Life Sciences

All rights reserved.